Perspective Therapeutics, Inc. (CATX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -31.47M | -24.66M | -16.29M | -19.95M | -21.58M | -26.61M | 3.37M | -8.9M | 13.85M | -9.01M | -10.11M | -8.07M | -9.72M | -2.89M | -1.76M | -2.89M | -1.42M | -1.31M | -2.08M | -1.12M |
| Operating CF Margin % | -41405.26% | - | -7795.22% | -6880.34% | - | - | - | - | - | -2673% | -529.6% | -538.13% | -531.31% | -157.55% | -102.68% | -115.41% | -48.87% | -46.63% | -81.28% | -41.25% |
| Operating CF Growth % | -45.81% | 7.33% | -584.02% | -124.14% | -255.85% | -195.36% | 133.29% | -10.28% | 242.43% | -211.59% | -473.45% | -179.21% | -583.76% | -120.18% | 15.4% | -158.59% | -128.99% | -72.76% | -516.57% | -31.84% |
| Net Income | -26.19M | -37.49M | -25.97M | -21.48M | -18.18M | -40.17M | -15.12M | -11.7M | -12.28M | -24.68M | -10.36M | -11.11M | -371K | -4.07M | -4.07M | -2.08M | -1.35M | -1.6M | -2.24M | -1.06M |
| Depreciation & Amortization | 1.13M | 1.01M | 775K | 733K | 732K | 721K | 669K | 570K | 346K | 262K | 259K | 245K | 180K | 83K | 68K | 65K | 64K | 60K | 59K | 42K |
| Stock-Based Compensation | 0 | 2.31M | 2.16M | 2.4M | 2.1M | 2.06M | 1.95M | 719K | 656K | 720K | 451K | 1.2M | 1.37M | 154K | 465K | 154K | 157K | 180K | 596K | 126K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -2.1M | 0 | 0 | 0 | 7.85M | 12K | 298K | -10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.14M | 8.83M | -544K | -691K | -852K | 24.32M | -485K | 10K | -266K | 4.86M | 68K | -12K | 42K | 2.19M | -33K | 22K | 18K | 19K | 18K | 21K |
| Working Capital Changes | -8.55M | 687K | 7.29M | -913K | -5.38M | -11.44M | 16.35M | 1.5M | 25.4M | 1.98M | -544K | 1.3M | -442K | -1.25M | 1.8M | -1.05M | -314K | 32K | -514K | -246K |
| Change in Receivables | -444K | 336K | 27K | -359K | -36K | 159K | 1.31M | 857K | 166K | 0 | -618K | 251K | -1K | 532K | 395K | 0 | -493K | 255K | 111K | 6K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16K | 27K | 102K | 113K | 16K | 128K | -2M | -95K | -2M | 84K | 43K | -796K | -133K |
| Change in Payables | -4.21M | -846K | 5.54M | -2.84M | -1.71M | -13.05M | 15.7M | 120K | -883K | 2.24M | -1.05M | 992K | -595K | 0 | 1.53M | 197K | -78K | 77K | 40K | -264K |
| Cash from Investing | -109.55M | 28.54M | 13.99M | 4.26M | -5.57M | -138.6M | -29.74M | -3.29M | -47.3M | -89K | -227K | -573K | 25.26M | -123K | -35.17M | -123K | -26K | -81K | -54K | -138K |
| Capital Expenditures | -6.86M | -5.08M | -1.99M | -1.03M | -4.66M | -14.61M | -29.71M | -1.01M | -9.07M | -89K | -227K | -555K | -201K | -105K | -90K | -105K | -26K | -81K | -54K | -115K |
| CapEx % of Revenue | 9023.68% | - | 953.11% | 353.79% | - | - | - | - | - | 26.41% | 11.89% | 37% | 10.98% | 5.72% | 5.24% | 4.19% | 0.89% | 2.88% | 2.11% | 4.24% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -51K | -39K | -36K | -9K | 287K | -24K | 0 | 0 | 0 | 0 | -18K | 0 | -18K | 0 | -18K | 35.08M | 0 | 0 | -23K |
| Cash from Financing | 164.36M | -13K | 213K | 132K | 9.97M | 345K | 628K | 122.08M | 166.33M | 352K | 1K | 512K | -80K | 0 | 28K | 0 | 28K | 56K | 0 | 243K |
| Debt Issued (Net) | -15K | -13K | -13K | -13K | -13K | -12K | -16K | -8K | -12K | -12K | - | - | - | 0 | - | - | - | - | - | - |
| Equity Issued (Net) | 164.38M | -371K | 226K | 145K | 9.99M | -11.89M | 0 | 235.04M | 53.14M | 364K | - | - | - | 0 | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 371K | 0 | 0 | 0 | 12.25M | 644K | -112.94M | 113.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 23.34M | 3.87M | -2.09M | -15.56M | -17.17M | -164.86M | -25.74M | 109.89M | 142.3M | -8.74M | -10.34M | -8.13M | 15.46M | 36.9M | -36.9M | -3.01M | -1.45M | -1.34M | -2.14M | -1.01M |
| Free Cash Flow | -38.33M | -29.73M | -18.28M | -20.98M | -26.24M | -41.22M | -26.35M | -9.92M | 4.78M | -9.1M | -10.34M | -8.63M | -9.92M | -3M | -1.85M | -3M | -1.45M | -1.39M | -2.14M | -1.23M |
| FCF Margin % | -50428.95% | - | -8748.33% | -7234.14% | - | - | - | - | - | -2699.41% | -541.49% | -575.13% | -542.3% | -163.27% | -107.92% | -119.6% | -49.76% | -49.5% | -83.39% | -45.5% |
| FCF Growth % | -46.07% | 27.87% | 30.6% | -111.55% | -649.37% | -353.12% | -154.88% | -14.95% | 148.13% | -203.64% | -457.85% | -187.95% | -585.36% | -114.92% | 13.33% | -142.98% | -102.8% | -70% | -374.06% | -41.24% |
| FCF per Share | -0.37 | -0.40 | -0.25 | -0.30 | -0.36 | -0.58 | -0.37 | -0.15 | 0.10 | -0.17 | -0.19 | -0.16 | -0.18 | -0.05 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.02 |
| FCF Conversion (FCF/Net Income) | 1.20x | 0.66x | 0.63x | 0.93x | 1.19x | 0.66x | -0.22x | 0.76x | -1.13x | 0.37x | 0.98x | 0.73x | 26.21x | 1.31x | 0.45x | 1.44x | 1.18x | 0.82x | 0.93x | 1.05x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - |